TheJobsMapDimerix Limited jobs and careers
Australia
About Dimerix Limited
Dimerix (ASX:DXB) is a clinical-stage biopharmaceutical company with a portfolio of drug candidates for inflammatory diseases, including kidney and respiratory diseases. Dimerix’ lead clinical asset, DMX-200 (or QYTOVRA® in some territories), is in Phase 3 trials as a treatment for focal segmental glomerulosclerosis (FSGS), a rare kidney disease.
Founded in 2004 by Liddy McCall.
- Founded
- 2004
- Employees
- 11 to 50
- Total funding
- $21M
- Headquarters
- Australia
Leadership
The top of Dimerix Limited's org chart, with how many people report into each leader.
NW
Nina Webster
CEO & Managing Director
Jobs at Dimerix Limited
No open positions right now. Explore more companies on TheJobsMap.